美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Eikon Therapeutics

11.24

+0.40003.69%

盤後：11.09-0.1500-1.33%19:54 EDT

成交量：14.60萬

成交額：164.37萬

市值：6.07億

市盈率：-1.82

高：11.55

開：11.09

低：10.91

收：10.84

52周最高：17.40

52周最低：8.58

股本：5,398.43萬

流通股本：1,764.80萬

量比：0.35

換手率：0.83%

股息：- -

股息率：- -

每股收益(TTM):-6.1630

每股收益(LYR):-115.2900

淨資產收益率：-125.02%

總資產收益率：-36.19%

市淨率：-0.69

市盈率(LYR):-0.10

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Eikon Therapeutics公布2025年第四季度及全年財報同步更新臨床進展與企業動態

BUZZ-隨着 IPO 研究平靜期的結束，由 Perlmutter 支持的 Eikon Therapeutics 股價上漲

美銀全球研究啓動對Eikon Therapeutics的覆蓋給予買入評級及34美元目標價

旗艦企業 Generate Biomedicines 希望在美國 IPO 中獲得 22 億美元估值

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/EIKN"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EIKN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EIKN\",,,,,undefined,":{"symbol":"EIKN","market":"US","secType":"STK","nameCN":"Eikon Therapeutics","latestPrice":11.24,"timestamp":1776369600000,"preClose":10.84,"halted":0,"volume":145959,"hourTrading":{"tag":"盘后","latestPrice":11.09,"preClose":11.24,"latestTime":"19:54 EDT","volume":32431,"amount":366536.05,"timestamp":1776383662950,"change":-0.15,"changeRate":-0.013345,"amplitude":0.062278},"delay":0,"changeRate":0.03690036900369007,"floatShares":17648000,"shares":53984300,"eps":-6.163,"marketStatus":"未開盤","change":0.4,"latestTime":"04-16 16:00:00 EDT","open":11.09,"high":11.55,"low":10.91,"amount":1643747.9798,"amplitude":0.059041,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.163,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"listingDate":1770267600000,"exchange":"NASDAQ","adjPreClose":10.84,"postHourTrading":{"tag":"盘后","latestPrice":11.09,"preClose":11.24,"latestTime":"19:54 EDT","volume":32431,"amount":366536.05,"timestamp":1776383662950,"change":-0.15,"changeRate":-0.013345,"amplitude":0.062278},"volumeRatio":0.345244},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EIKN\",,,,,undefined,":{"symbol":"EIKN","floatShares":17648000,"roa":"-36.19%","roe":"-125.02%","lyrEps":-115.29,"volumeRatio":0.345244,"shares":53984300,"dividePrice":0,"high":11.55,"amplitude":0.059041,"preClose":10.84,"low":10.91,"week52Low":8.58,"pbRate":"-0.69","week52High":17.4,"institutionHeld":0,"latestPrice":11.24,"eps":-6.163,"divideRate":0,"volume":145959,"delay":0,"ttmEps":-6.163,"open":11.09,"prevYearClose":18,"prevWeekClose":9,"prevMonthClose":10.58,"prevQuarterClose":10.58,"fiveDayClose":9.01,"twentyDayClose":11.74,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EIKN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EIKN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EIKN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.6667,"hold":0,"sell":0,"strongSell":0.1667,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1774929600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EIKN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EIKN","date":"2026-04-15","current":-1.823787,"percent":0.765957,"low":-3.139466,"twenty":-2.596338,"median":-2.334542,"eighty":-1.731195,"high":-1.465966,"avg":-2.207406,"sd":0.428029,"marketCap":574410068},"quantilePoints":[{"date":"2026-02-06","current":-2.616222,"twenty":-3.034817,"median":-2.877844,"eighty":-2.720871,"marketCap":809765055},{"date":"2026-02-13","current":-2.586571,"twenty":-2.610292,"median":-2.537735,"eighty":-2.527619,"marketCap":800587717},{"date":"2026-02-20","current":-2.703429,"twenty":-2.7418,"median":-2.616222,"eighty":-2.529014,"marketCap":836757223},{"date":"2026-02-27","current":-2.379017,"twenty":-2.703429,"median":-2.596164,"eighty":-2.52727,"marketCap":736346356},{"date":"2026-03-06","current":-2.535991,"twenty":-2.644128,"median":-2.595292,"eighty":-2.523782,"marketCap":784932259},{"date":"2026-03-13","current":-2.054606,"twenty":-2.624942,"median":-2.562153,"eighty":-2.406924,"marketCap":635935489},{"date":"2026-03-20","current":-1.915074,"twenty":-2.616222,"median":-2.529014,"eighty":-2.298787,"marketCap":592748020},{"date":"2026-03-27","current":-1.836588,"twenty":-2.600524,"median":-2.515933,"eighty":-2.054606,"marketCap":568455068},{"date":"2026-04-02","current":-1.678228,"twenty":-2.599129,"median":-2.426109,"eighty":-1.985189,"marketCap":544162116},{"date":"2026-04-10","current":-1.504368,"twenty":-2.597385,"median":-2.379017,"eighty":-1.821565,"marketCap":487788380},{"date":"2026-04-15","current":-1.771515,"twenty":-2.596338,"median":-2.334542,"eighty":-1.731195,"marketCap":574410068}],"updateTime":1776411832259},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EIKN\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1198302033","title":"Eikon Therapeutics公布2025年第四季度及全年財報 同步更新臨床進展與企業動態","url":"https://stock-news.laohu8.com/highlight/detail?id=1198302033","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198302033?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 19:49","pubTimestamp":1774871395,"startTime":"0","endTime":"0","summary":"Eikon Therapeutics近日正式披露2025年第四季度及全年财务业绩报告，同时就核心临床项目进展与公司战略规划进行同步更新。此次公告全面呈现了公司在财务表现、研发管线及运营层面的最新态势。此次综合更新不仅彰显了Eikon Therapeutics以技术驱动创新的发展路径，也反映出其通过跨学科平台加速药物发现的长期承诺。公司表示将继续推进临床阶段项目的全球化布局，同时加强财务稳健性以支持未来增长计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EIKN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616505273","title":"BUZZ-隨着 IPO 研究平靜期的結束，由 Perlmutter 支持的 Eikon Therapeutics 股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2616505273","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616505273?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 02:10","pubTimestamp":1772475022,"startTime":"0","endTime":"0","summary":"3月2日 - ** 默克公司资深员工珀尔穆特领导的药物开发商Eikon TherapeuticsEIKN.O股价上涨3.9%至14.31美元。** 随着首次公开募股研究平静期的结束，至少有三家华尔街券商开始给予看涨评级** 摩根大通表示：\"EIKN 的投资组合以 Keytruda 前开发者为首，具有战略定位，通过内授权拥有两项先进资产，并通过其超分辨率显微镜发现引擎建立了自己的管线。** EIKN 上个月在纽约上市 ，首次公开募股定价为每股 18 美元， ，共售出 2120 万股。** 截至上次收盘，EIKN 股价自二月上市以来下跌了 23%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL4S3ZQ1UU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU2265009873.SGD","BK4207","LU0130102774.USD","LU0211331839.USD","LU0149725797.USD","LU0203345920.USD","LU1804176565.USD","LU1989772840.SGD","LU1037948541.HKD","LU0122379950.USD","LU1280957306.USD","LU2129689514.USD","BK4007","LU0130103400.USD","LU1023059063.AUD","LU1201861165.SGD","BK4559","LU0683600562.USD","LU1880398471.USD","LU0985320562.USD","BK4553","LU0256863902.USD","LU0310800965.SGD","LU0106831901.USD","LU0070302665.USD","LU1037948897.HKD","IE00BLSP4452.SGD","SGXZ57979304.SGD","IE0002270589.USD","LU0965509283.SGD","LU0965509010.AUD","LU0098860793.USD","BK4588","BK4585","LU1880398554.USD","SG9999014542.SGD","LU1035773651.USD","LU0006306889.USD","LU1989771016.USD","LU2023250504.SGD","LU0203347892.USD","BK4139","IE00B19Z3581.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU2133065610.SGD","LU1934455277.USD","LU2324357040.USD","IE00BFXG1179.USD","LU2361044949.HKD","LU1894683348.USD","LU1057294990.SGD","LU0306806265.USD","LU1791807156.HKD","LU2360032135.SGD","LU0208291251.USD","LU0238689110.USD","LU1983299246.USD","IE00B19Z3B42.SGD","LU1917777945.USD","LU1934455863.HKD","IE00BBT3K403.USD","IE00B7SZLL34.SGD","LU0648000940.SGD","LU0321505439.SGD","LU0417517546.SGD","LU1066053197.SGD","LU0170899867.USD","LU2361045086.USD","SG9999002232.USD","LU0265550946.USD","LU2461242641.AUD","LU1116320737.USD","LU2023250843.SGD","LU1116320901.HKD","LU0320765646.SGD","LU0052756011.USD","LU1929549753.HKD","SG9999015341.SGD","LU2106854487.HKD","LU0980610538.SGD","LU1074936037.SGD","LU1093756168.USD","LU1974910355.USD","SG9999001176.SGD","LU0130517989.USD","SG9999002224.SGD","LU1883839398.USD","LU0234572021.USD","LU0289739699.SGD","LU2129689431.USD","LU0266013472.USD","LU0477156953.USD","SG9999014575.USD","SG9999015358.SGD","IE00BJT1NW94.SGD","LU2112291526.USD","IE00BZ1G4Q59.USD","IE00B4R5TH58.HKD","LU0128525689.USD","LU2125154935.USD","LU0256863811.USD","LU1061106388.HKD","LU0306807586.USD","LU1699723380.USD","IE00BLSP4239.USD","LU1941712348.USD","LU1201861249.SGD","IE00BJJMRZ35.SGD","LU0053666078.USD","BK4533","LU1506573853.SGD","LU1668664300.SGD","IE0034235188.USD","LU1894683264.USD","LU1934455194.USD","SG9999001176.USD","LU0477156797.USD","LU0648001328.SGD","LU1496350502.SGD","LU1069347547.HKD","LU1585245621.USD","LU0787776722.HKD","LU1496350171.SGD","LU1066051225.USD","LU0971096721.USD","LU2361044865.SGD","IE00BKVL7J92.USD","LU1430594728.SGD","LU0868494617.USD","LU1291159041.SGD","SG9999014567.USD","LU2468319806.SGD","LU1162221912.USD","LU1093756325.SGD","LU0106261372.USD","SG9999001440.SGD","BK4516","BK4534","LU0965509101.SGD","IE00BFTCPJ56.SGD","BK4581","IE0009355771.USD","SG9999013999.USD","LU1366192091.USD","EIKN","LU0130518102.USD","LU1941712264.USD","SG9999014559.SGD","LU1066051811.HKD","LU0321505868.SGD","LU0234570918.USD","LU1718418525.SGD","LU0265550359.USD","LU0432979614.USD","BK4550","IE0001KFT4U8.USD","LU0965508806.USD","LU0861579265.USD","LU2129689605.HKD","IE0002141913.USD","LU2089984988.USD","LU0640476718.USD","LU1267930227.SGD","LU2125154778.USD","IE00BSNM7G36.USD","LU0314106906.USD","LU0320765489.SGD","LU1363072403.SGD","IE00B1BXHZ80.USD","IE00BN8TJ469.HKD","LU1989772923.USD","IE00B2B36J28.USD","LU1571399168.USD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136724466","title":"美銀全球研究啓動對Eikon Therapeutics的覆蓋 給予買入評級及34美元目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1136724466","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136724466?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 19:43","pubTimestamp":1772451794,"startTime":"0","endTime":"0","summary":"美银全球研究近日宣布，正式启动对生物科技公司Eikon Therapeutics（股票代码：EIKN）的研究覆盖，并首次给予\"买入\"评级。该机构同时设定了34美元的目标股价，显示出对该公司未来增长前景的积极预期。\n此次覆盖启动标志着华尔街主要机构对Eikon Therapeutics在创新药物开发领域技术实力的认可。分析师在报告中指出，公司独特的平台技术和研发管线布局为其长期价值提升奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EIKN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613789435","title":"旗艦企業 Generate Biomedicines 希望在美國 IPO 中獲得 22 億美元估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2613789435","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613789435?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 19:54","pubTimestamp":1771847674,"startTime":"0","endTime":"0","summary":"更新版 3-旗舰企业 Generate Biomedicines 希望在美国 IPO 中获得 22 亿美元估值在第 3、6、7 段添加分析师评论Arasu Kannagi Basil路透2月23日 - 药物开发商Generate Biomedicines周一表示，该公司在美国首次公开募股的目标估值将高达21.7亿美元，从而进入上市步伐加快的生物技术市场。Aktis Oncology AKTS.O、Agomab Therapeutics AGMB.O、Veradermics MANE.N、Eikon Therapeutics EIKN.O和SpyGlass Pharma SGP.O今年已经登陆美国资本市场。\"Generate公司用于治疗严重哮喘的主要候选产品GB-0895正在进行后期试验。预计这项研究将于 2028 年上半年全部完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL4S3ZJ0Q2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","LU0122379950.USD","AKTS","IE0004091025.USD","MRNY","MRNX","MANE","LU0098860793.USD","LU0234570918.USD","BK4532","LU0889565916.HKD","LU1162221912.USD","BK4516","LU0251142724.SGD","BK4552","LU1244550494.USD","IE00B2B36J28.USD","LU0912757837.SGD","LU1868836757.USD","EIKN","LU0096364046.USD","LU1791807156.HKD","LU2028103732.USD","LU2111349929.HKD","SGP","LU2750360997.AUD","BK4139","LU2471134796.USD","MRNA","BK4550","GSX","LU1868836914.USD","BK4534","IE00BJJMRZ35.SGD","LU0795875169.SGD","LU0106261372.USD","BK4127","LU0320765992.SGD","LU2237443465.HKD","IE0009355771.USD","LU2265009873.SGD","LU2750360641.GBP","LU2089283258.USD","LU2133065610.SGD","IE00BKVL7J92.USD","LU1804176565.USD","LU2237443622.USD","BK4566","PIPR","AGMB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EIKN\",params:#limit:6,delay:false,,,undefined,":[]}}